11
5
2
Cat. No. | Product Name | ||
---|---|---|---|
L5900 | 血脑屏障通透化合物库 | 509 compounds | |
509 个 CNS-Penetrant 生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2600 | 神经信号分子库 | 2540 compounds | |
2540 种CNS 相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L7700 | 神经再生化合物库 | 524 compounds | |
524 种神经再生相关化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
1513 种与神经递质受体相关的化合物,用于高通量、高内涵筛选; | |||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 237 compounds | |
237 个Wnt & Hedgehog & Notch 靶点相关的生物活性小分子化合物的特有集合,用于相关通路的研究及药物的筛选,可用于高通量、高内涵筛选。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T4316 |
ML365
|
Potassium Channel | Membrane transporter/Ion channel |
ML365 是有效的,选择性的双孔结构域钾通道TASK1/KCNK3抑制剂,IC50为 4 nM。它可用于检查 TASK1 通道的特定作用。 | |||
T9713 |
δ-secretase inhibitor 11
|
Beta Amyloid; Caspase | Apoptosis; Neuroscience; Proteases/Proteasome |
δ-secretase inhibitor 11是一种分泌酶抑制剂,可用作 阿尔茨海默病(AD) 治疗转化开发的先导化合物。 | |||
T26719 |
AZD6538
AZD 6538,AZD-6538 |
GluR | Neuroscience |
AZD6538 是一种 mGluR5 负异位调节剂,可用于研究阿尔茨海默症等中枢神经系统相关疾病。 | |||
T9786 |
Lu AF27139
|
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
Lu AF27139 是一种有效的选择性 P2X7 受体拮抗剂(人和大鼠的 IC50 分别为 12 和 2.4 nM,小鼠、人和大鼠的 Ki 分别为 22、54 和 13 nM)。 Lu AF27139 可用于中枢神经系统疾病研究。 | |||
T9729 |
AGI-43192
|
Others | Others |
AGI-43192是一种有效的,可渗透进血脑屏障的蛋氨酸腺苷转移酶 2A (MAT2A) 抑制剂。AGI-43192抑制 s -腺苷蛋氨酸(SAM)生成代谢酶和蛋氨酸腺苷转移酶2A (MAT2A),具有研究 SAM 调节在中枢神经系统 (CNS) 中的作用和治疗癌症疾病的潜力。 | |||
T61025 |
GSK-1482160
|
P2X Receptor | Membrane transporter/Ion channel; Neuroscience |
GSK-1482160是一种CNS-渗透的P2X7受体负变构调节剂,具有口服活性。P2X7受体参与中枢和外周免疫细胞产生促炎细胞因子,因此GSK-1482160具有研究炎症性疾病的潜力。GSK-1482160具有出色的体外效价(在包括人类在内的多种物种的重组和初始P2X7受体的功能和电生理测试中)和交叉靶标选择性。 | |||
T26690 |
AVN-101
|
5-HT Receptor; Adrenergic Receptor; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
AVN-101 是一种非常有效的 5-HT7 受体拮抗剂 (Ki = 153 pM)。 AVN-101 还对组胺 H1 (Ki = 0.58 nM) 和肾上腺素能 α2A、α2B 和 α2C (Ki = 0.41-3.6 nM) 受体表现出相当高的亲和力。 AVN-101在中枢神经系统疾病动物模型中显示出良好的口服生物利用度和促进脑血屏障通透性、低毒性和合理的疗效。 | |||
T62517 |
S1p receptor agonist 2
|
Others | Others |
S1p receptor agonist 2 (compound 1) 是一种 S1P5 受体的激动剂,选择性比 S1P1 和/或 S1P3 受体高。S1p receptor agonist 2 能够用于内源性 SIP 信号系统,以及减轻/预防中枢神经系统 (CNS) 疾病 (如神经退行性疾病) 的演技。 | |||
T61073 |
KH-259
|
Others | Others |
KH-259 (compound 1) is a highly potent, selective, and CNS-penetrant HDAC6 inhibitor, demonstrating an IC50 of 0.26 μM. It exerts its antidepressant effects in mice by inhibiting HDAC6 within the brain. Therefore, KH-259 holds promise as a valuable tool for neurodegenerative diseases research [1]. | |||
T79212 |
mTOR inhibitor-12
|
mTOR | PI3K/Akt/mTOR signaling |
mTORinhibitor-12(Compound 11)为选择性脑渗透性mTOR抑制剂,无遗传毒性风险,适用于中枢神经系统疾病研究。 | |||
T81637 |
NT-0796
|
NOD-like Receptor (NLR) | Immunology/Inflammation |
NT-0796为一种选择性穿透中枢神经系统的NLRP3炎性体抑制剂,其PBMC方法中的IC50值为0.32 nM。该化合物为异丙酯类,能够在细胞内转化为NDT-197959(羧酸活性物)。NT-0796在神经炎症疾病研究中显示出潜力。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00332 |
tPA Protein, Human, Recombinant (His)
TPA,T-PA,t-plasminogen activator,Tissue plasminogen activato... |
Human | HEK293 Cells |
Tissue-type plasminogen activator (PLAT) is a protein that secreted into extracellular space. PLAT contains five domains: EGF-like domain, fibronectin type-I domain, 2 kringle domains and peptidase S1 domain. It belongs to the peptidase S1 family. The main function of this protein is to convert plasminogen into biologically active plasmin. As a protease, PLAT plays a crucial role in regulating blood fibrinolysis, maintaining the homeostasis of extracellular matrix and in modulating the post-tra... | |||
TMPY-01290 |
CHIT1 Protein, Human, Recombinant (His)
chitinase 1 (chitotriosidase),CHITD,CHI3,CHIT |
Human | HEK293 Cells |
Chitotriosidase, also known as Chitinase-1 and CHIT1, is a member of the glycosyl hydrolase 18 family and Chitinase class II subfamily. It is a member of the mammalian chitinase family, structurally homologous to chitinases from other species, is synthesized and secreted by specifically activated macrophages. Chitotriosidase is a polymer of N-acetylglucosamine. Serum and plasma chitotriosidase activity is usually measured as the first step in diagnosis of Gaucher disease. Monitoring chitotriosid... |